Pharmax
Pharmax, a leading name in the pharmaceutical industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2001, the company has established itself as a key player in the development and manufacturing of high-quality generic and specialty pharmaceuticals. Pharmax is renowned for its innovative approach to drug formulation, offering a diverse portfolio that includes injectables, oral solids, and complex generics. Their commitment to quality and regulatory compliance has earned them a strong market position, with notable achievements in product approvals and partnerships. With a focus on enhancing patient outcomes, Pharmax continues to push the boundaries of pharmaceutical excellence, making significant strides in both research and development.
DitchCarbon Score
How does Pharmax's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmax's score of 3 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmax's reported carbon emissions
Pharmax, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the absence of emissions data suggests that Pharmax may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, it is essential for companies like Pharmax to establish clear climate commitments and reduction targets to align with global efforts to mitigate climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmax is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
